KR102844796B1 - 프로게스테론 질내 장치 - Google Patents

프로게스테론 질내 장치

Info

Publication number
KR102844796B1
KR102844796B1 KR1020207030158A KR20207030158A KR102844796B1 KR 102844796 B1 KR102844796 B1 KR 102844796B1 KR 1020207030158 A KR1020207030158 A KR 1020207030158A KR 20207030158 A KR20207030158 A KR 20207030158A KR 102844796 B1 KR102844796 B1 KR 102844796B1
Authority
KR
South Korea
Prior art keywords
progesterone
ring
vaginal
intravaginal
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020207030158A
Other languages
English (en)
Korean (ko)
Other versions
KR20200135443A (ko
Inventor
마그로 콘셉시온 니에토
에르난도 엘레나 페레스
델 프라도 하이메 모스코소
알마르사 하비에르 수아레스
Original Assignee
아이티에프 리서치 파마, 에스.엘.유.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아이티에프 리서치 파마, 에스.엘.유. filed Critical 아이티에프 리서치 파마, 에스.엘.유.
Publication of KR20200135443A publication Critical patent/KR20200135443A/ko
Application granted granted Critical
Publication of KR102844796B1 publication Critical patent/KR102844796B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
KR1020207030158A 2018-03-21 2019-03-21 프로게스테론 질내 장치 Active KR102844796B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18382190.9 2018-03-21
EP18382190.9A EP3542786A1 (en) 2018-03-21 2018-03-21 Progesterone intravaginal devices
PCT/EP2019/057074 WO2019180133A1 (en) 2018-03-21 2019-03-21 Progesterone intravaginal devices

Publications (2)

Publication Number Publication Date
KR20200135443A KR20200135443A (ko) 2020-12-02
KR102844796B1 true KR102844796B1 (ko) 2025-08-08

Family

ID=61768237

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207030158A Active KR102844796B1 (ko) 2018-03-21 2019-03-21 프로게스테론 질내 장치

Country Status (7)

Country Link
US (1) US11278491B2 (enExample)
EP (2) EP3542786A1 (enExample)
JP (1) JP7391863B2 (enExample)
KR (1) KR102844796B1 (enExample)
CN (1) CN112469392A (enExample)
CA (1) CA3094420C (enExample)
WO (1) WO2019180133A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3542786A1 (en) 2018-03-21 2019-09-25 ITF Research Pharma, S.L.U. Progesterone intravaginal devices
CN114126710A (zh) * 2019-03-29 2022-03-01 B·马特尔 含有孕酮的eva分段式阴道内环
CN121243071A (zh) * 2025-10-30 2026-01-02 南京帝昌医药科技有限公司 一种雌激素阴道泡沫剂及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090202612A1 (en) * 2008-02-04 2009-08-13 Ahmed Salah U Monolithic Intravaginal Rings Comprising Progesterone and Methods of Making and Uses Thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816257A (en) * 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
US5869081A (en) 1996-06-28 1999-02-09 The Population Council Progesterone vaginal ring for treatment of infertility
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US20170224823A1 (en) 2014-10-22 2017-08-10 International Partnership For Microbicides, Inc. Platinum-catalyzed silicone drug delivery devices and methods of use thereof
EP3542786A1 (en) 2018-03-21 2019-09-25 ITF Research Pharma, S.L.U. Progesterone intravaginal devices

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090202612A1 (en) * 2008-02-04 2009-08-13 Ahmed Salah U Monolithic Intravaginal Rings Comprising Progesterone and Methods of Making and Uses Thereof

Also Published As

Publication number Publication date
CA3094420A1 (en) 2019-09-26
KR20200135443A (ko) 2020-12-02
WO2019180133A1 (en) 2019-09-26
CA3094420C (en) 2024-06-25
CN112469392A (zh) 2021-03-09
JP7391863B2 (ja) 2023-12-05
EP3768235A1 (en) 2021-01-27
JP2021518405A (ja) 2021-08-02
US11278491B2 (en) 2022-03-22
RU2020131251A (ru) 2022-04-22
US20210030666A1 (en) 2021-02-04
EP3542786A1 (en) 2019-09-25

Similar Documents

Publication Publication Date Title
Vannuccini et al. Role of medical therapy in the management of uterine adenomyosis
US20230158044A1 (en) Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
JP7391863B2 (ja) プロゲステロン膣内デバイス
BG106442A (bg) Мезопрогестини (прогестерон рецептор модулатори) за лечение и профилактика на хормонозависими доброкачествени гинекологични заболявания
RU2830189C2 (ru) Интравагинальные устройства, содержащие прогестерон
AU2016202114B2 (en) Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
AU2013203779B2 (en) Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
KR20260012702A (ko) 효과적인 피임의 제공 방법 및 장치
Schreiber et al. Revised 11 January 2018
Daftary Oral Contraception
JP2007197459A (ja) 月経の出血を少なくし維持された効力を持つ超低投与量避妊薬

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

F11 Ip right granted following substantive examination

Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

U12 Designation fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)